SNSE FDA Decision CRL · 2025-10-17
Mislabel — ESMO Phase 1/2 clinical data, clinical-stage
Price into the decision (T-120)
Historical price action; green = local high, red = low/sell-off.
Decision facts
FDA decision date2025-10-17
Outcome✗ CRL⚠ label corrected
Decision-day move-33.4%
T-120 run-up (low→high)+170.0% ($6.52→$17.58)
CRL reasonMislabel — ESMO Phase 1/2 clinical data, clinical-stage
pdufa.bio · access required